Drug Type Dual payload Antibody drug conjugate (Dual payload ADC) |
Synonyms ALM 502, ALM502 |
Target |
Action inhibitors |
Mechanism ALPP inhibitors(alkaline phosphatase, placental inhibitors), ALPPL2 inhibitors(alkaline phosphatase, germ cell inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | - | - | 20 Apr 2026 |
| Solid tumor | Preclinical | United Kingdom | 01 Apr 2026 |






